Related Experiment Videos

TCT.1: a target structure for a subpopulation of human gamma/delta T lymphocytes

F Mami-Choubaid¹, T Hercend

¹"Laboratoire d'Immunologie Cellulaire", INSERM, U333, Institut Gustave-Roussy, Villejuif, France.

Current Topics in Microbiology and Immunology

|January 1, 1991

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission.

European cytokine network·2000

Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patients.

Journal of immunotherapy (Hagerstown, Md. : 1997)·1999

A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion.

European journal of immunology·1999

A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation.

European journal of immunology·1999

A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia.

Leukemia & lymphoma·1998

Analysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity.

International journal of cancer·1997

See all related articles